The Company operates across 5 strategic business units and a corporate headquarters across its geographic footprint.
We develop, manufacture and market exclusive prescription brand medicines in Latin America
We develop, manufacture and market highly complex medicines used for critical processings in the hospital sector.
We develop, manufacture, and market quality over-the-counter ("OTC") and generic health products for the entire family.
We provide well-being and quality of life to people with diabetes (PWD) and their environment, being their ally for the effective management of their chronic condition.
Contract Development and Manufacturing ("CDMO") services in advanced softgel technologies for the global pharmaceutical and nutraceutical industry
Procaps is a pharmaceutical group dedicated to delivering health and nutrition.
A leading marketer of advanced-softgel related technologies.
Facilities of advanced-softgel related technologies.
We employ over 5,000 people across 13 countries.
+10 pharmaceutical forms +136 Billons Capsules fabricated.
Global distribution in over 50 countries.
Our vertical integration allows us to offer end-to-end solutions across the value chain.
Deep scientific expertise with more than 500 Formulations and 50 new launches per year.
Convinced of the importance of operating with a Quality and Comprehensive Management System and of the benefits and added value that this offers to an organization, we have committed ourselves to the development of each of the objectives set for this purpose, with the constant search for Continuous Improvement of processes to comply with applicable standards and legislation, promote safe international trade, prevent risks, guarantee safe and healthy working conditions, manage innovation and improve our performance in relation to Quality, Environment and Control and security.
The Quality and Integral Management System follows the guidelines of the NTC-ISO 9001:2015, NTC-ISO 14001:2015, NTC-ISO 45001:2018, NTC-5801:2018 Standards, Zero Waste Management System and those of the Control and Safety Management BASC V6: 2022, and covers the manufacture and marketing of pharmaceutical products for human use, dietary supplements, Phyto therapeutics, by defining the interaction between the processes of the Organization, the assurance in the provision of necessary resources for its effective development, and the performance of feedback and response actions that allow maintaining and improving the performance of each process and of the organization in general.